Disclosed herein are antibodies and antigen binding fragments that bind phosphorylated and dephosphorylated tau and methods of use in detecting and treating Alzheimer's disease and other tauopathies. Also included are methods for determining the stage of Alzheimer's disease in a human subject and monitoring the effectiveness of an anti-tau therapy.